Action of cannabidiol on the anxiety and other effects produced by δ9-THC in normal subjects - Psychopharmacology
- ️Karniol, I. G.
- ️Mon Mar 01 1982
Agurell S, Levander S, Bindler M, Bader-Bartfai A, Gustafson B, Leander K, Lindgren J, Ohlsson A, Tobisson B (1976) Pharmacokinetics of Δ 8-tetrahydrocannabinol (Δ 6-tetrahydrocannabinol) in man after smoking — Relations to physiological and psychological effects. In: Braude MC, Szara S (eds) The pharmacology of marihuana. Raven Press, New York, pp 49–61
Bech P, Rafaelsen L, Rafaelsen OJ (1974) Cannabis: A psychopharmacological review. Dan Med Bull 21 (3):106–120
Biaggio AMB, Natalício L, Spielberger CD (1977) Desenvolvimento da forma experimental em portugues do Inventário de Ansiedade. Traço — Estado (IDATE), de Spielberger. Arquivos Brasileiros de Psicologia Aplicada 29:31–44
Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218
Borg J, Gerson S, Alpert M (1975) Dose effects of smoked marihuana on human cognitive and motor functions. Psychopharmacologia 42:211–218
Bussab WO (1976) Hierarchical dichotomous partitions in cluster analysis. PhD Thesis, University of London
Cappell H, Kuchar E (1974) Pharmacologic and nonpharmacologic factors in marijuana intoxication. Clin Toxicol 7:315
Carlin AS, Bakker CB, Halpern L, Post RD (1972) Social facilitation of marijuana intoxication: Impact of social set and pharmacological activity. J Abnorm Psychol 80:132–140
Carlini EA, Leite JR, Tanhauser M, Berardi AC (1973) Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents. J Pharm Pharmacol 25:664–665
Carlini EA, Masur J, Magalhães CCPB (1979) Possível efeito hipnótico do canabidiol no ser humano. Estudo preliminar. Cìência e Cultura 31:315–322
Cunha JM (1979) O efeito anti-epiléptico do canabidiol. Tese de doutoramento apresentada a Escola Paulista de Medicina, São Paulo
Dalton WS, Martz R, Lemberger L, Rodda BE, Forney B (1976) Influence of cannabidiol on Δ 9-tetrahydrocannabinol effects. Clin Pharmacol Ther 19:300–309
Davis WM, Borgen LA (1974) Effects of cannabidiol and Δ 9-tetrahydrocannabinol on operant behavior. Res Commun Chem Pathol Pharmacol 9:453–462
Fernandes M, Schabarek A, Coper H, Hill R (1974) Modification of Δ 9-THC actions by cannabinol and cannabidiol in the rat. Psychopharmacologia 38:329–338
Galanter M, Wyatt RJ, Lemberger L, Weingartner H, Vaughan TB, Roth WT (1972) Effects on humans of Δ 9-tetrahydrocannabinol administered by smoking. Science 176:934–936
Gregg JM, Small EW, Moore R, Raft D, Toomey TC (1976) Emotional response to intravenous Δ 9-tetrahydrocannabinol during oral surgery. J Oral Surg 34:301–313
Grlic L (1976) A comparative study on some chemical and biological characteristics of various samples of cannabis resin. Bull Narcot 14:37–46
Haertzen CA, Hill HE, Belleville RE (1963) Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs. Psychopharmacologia 4:155–166
Hollister LE (1971) Manhuana in man: three yeas later. Science 172:21–29
Hollister LE (1973) Cannabidiol and cannabinol in man. Experientia 29:825–826
Hollister LE, Gillespie H (1975) Interactions in man of Δ 9-tetrahydrocannabinol. II-Cannabinol and Cannabidiol. Clin Pharmacol Ther 18:80–83
Hollister LE, Richards RK, Gillespie H (1968) Comparison of tetrahydrocannabinol and synhexil in human. Clin Pharmacol Ther 9 (6):783–791
Isbell H, Jasinski DR (1969) A comparison of LSD-25 with (-)Δ 9-tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC. Psychopharmacologia 14:115–123
Jones RT (1971) Tetrahydrocannabinol and the marijuana — Induced social “high”, or the effects of the mind on marijuana. In: Singer AD (ed) Marijuana. Chemistry, Pharmacology, and Patterns of Social Use. New York Academy of Sciences, pp 155–165
Jones RT (1978) Marihuana: Human effects. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of Psychopharmacology. Drugs of Abuse. Plenum Press, New York, pp 373–412
Karniol IG, Carlini EA (1973) Comparative studies in man and in laboratory animals on Δ 8- and Δ 9-trans-tetrahydrocannabinol. Pharmacology 9:115–126
Karniol IG, Dalton J, Lader M (1976) Comparative psychotropic effects of trazodone imipramine and diazepam in normal subjects. Curr Ther Res 20 (3):337–347
Karniol IG, Dalton J, Lader M (1978) Acute and chronic effects of lithium chloride on physiological and psychological measures in normals. Psychopharmacology 57:289–294
Karniol IG, Shirakawa I, Kasinski N, Pfeferman A, Carlini EA (1974) Cannabidiol interferes with the effects of Δ 9-tetrahydrocannabinol in man. Eur J Pharmacol 28:172–177
Kiplinger GF, Manno JE, Rodda BE, Forney RB (1971) Dose-response analysis of the tetrahydrocannabinols in man. Clin Pharmacol Ther 12:650–657
Klapper JA, McCulloch MA, Sidell RF (1972) The effect on personality of reactivity to 1,2-dimethyl-heptyl tetrahydrocannabinol. Arch Gen Psychiatry 26:483–485
Malit LA, Johnstone RF, Bourke DI, Kulp RA, Klein D, Eng D, Smith DC (1975) Intravenous Δ 9-tetrahydrocannabinol: effects on ventilatory control and cardiovascular dynamics. Anesthesiol 42:666–673
Martz R, Brown DJ, Forney RB, Bright TP, Kiplinger GF, Rodda BE (1972) Propanolol antagonism of marihuana induced tachycardia. Life Sci 11:999–1005
Meyer RE (1978) Behavioral pharmacology of marihuana. In: Lipton MA, Dimascio A, Killam KF (eds) Psychopharmacology: A generation of progress. Raven Press, New York, pp 1634–1652
Miller LL, Cornett TL (1978) Marijuana: dose effects on pulse rate, subjective estimates of intoxication free recall and recognition memory. Pharmacol Biochem Behav 9:573–577
Monti JM (1977) Hypnoticlike effects of cannabidiol in the rat. Psychopharmacology 55:263–265
Naliboff BD, Rickles WH, Cohen MJ, Naimark RS (1976) Interactions of marijuana and induced stress: forearm blood flow heart rate, and skin conductance. Psychophysiology 13:517–522
Norris H (1971) The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology 10:181–191
Perez-Reyes M, Timmons MC, Dauls KH, Wall ME (1973) A comparison of the pharmacological activity in man of the intravenously administered Δ 9-tetrahydrocannabinol, cannabinol and cannabidiol. Experientia 29:1368–1369
Pillard RC, McNair DM, Fisher S (1974) Does marijuana enhance experimental induced anxiety? Psychopharmacologia 40:205–210
Rossi AM, Kuehnle JC, Mendelson JH (1978) Marihuana and mood in human volunteers. Pharmacol Biochem Behav 8:447–455
Scott AJ, Knott M (1974) A cluster analysis method for grouping means in the analysis of variance. Biometrics 30:507–512
Siegel S (1956) Nonparametric statistics for the behavioral sciences. McGraw-Hill e Kogakusha, Ltd., Japan
Spielberger CD, Gorsuch RL, Lushene RE (1970) Manual for the State-Trait Anxiety Inventory. Consulting Psychologist Press, Palo Alto, CA
Szara S (1976) Clinical pharmacology of cannabis: scientific and nonscientific constrainst. In: Braude MC, Szara S (eds) The pharmacology of marihuana. Raven Press, New York, pp 22–33
Tassinari CA, Ambrosetto G, Peraita-Adrados MR, Gestaut H (1976) The neuropsychiatric syndrome of Δ 9-tetrahydrocannabinol and cannabis intoxication in naive subjects: a clinical and poligraphic study during wakefulness and sleep. In: Braude MC, Szara S (eds) The pharmacology of marihuana. Raven Press, New York
Weil AT, Zinberg NE, Nelsen JM (1968) Clinical and psychological effects of marihuana in man. Science 162:1234–1242
Zuardi AW, Karniol IG (1981) Estudo transcultural de uma escala de auto-avaliação para estados subjectivos. J Brasileiro de Psiquiatria (in press)